Catalent Inc (CTLT)
Debt-to-assets ratio
Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Total assets | US$ in thousands | 9,753,000 | 9,879,000 | 9,988,000 | 10,023,000 | 10,777,000 | 10,830,000 | 11,148,000 | 10,206,000 | 10,508,000 | 10,322,000 | 10,203,000 | 10,183,000 | 9,112,000 | 8,769,100 | 8,198,100 | 7,984,200 | 7,777,000 | 7,079,600 | 6,195,300 | 6,119,500 |
Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
June 30, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $9,753,000K
= 0.00
The debt-to-assets ratio for Catalent Inc has consistently been reported as 0.00 for the periods indicated in the table. This implies that the company has not had any debt in relation to its assets over the specified time frame. A debt-to-assets ratio of 0.00 typically suggests that the company is not relying on debt to finance its operations and that it has a strong financial position with a low risk of financial distress due to debt obligations. It indicates that all assets are funded through equity or other non-debt sources, which can be viewed positively by investors and creditors.
Peer comparison
Jun 30, 2024
Company name
Symbol
Debt-to-assets ratio
Catalent Inc
CTLT
0.00
Abbott Laboratories
ABT
0.19
AbbVie Inc
ABBV
0.00
Alkermes Plc
ALKS
0.13
Amphastar P
AMPH
0.40
ANI Pharmaceuticals Inc
ANIP
0.31
Arcus Biosciences Inc
RCUS
0.00
Biomarin Pharmaceutical Inc
BMRN
0.09
Bristol-Myers Squibb Company
BMY
0.39
Catalyst Pharmaceuticals Inc
CPRX
0.00
Collegium Pharmaceutical Inc
COLL
0.42